Genetic test analysis company has cracked the code

A key pivot from end users to health insurance plans opened a lucrative growth phase for the St. Petersburg firm. Can it convince its clients to stick with outsourcing?


  • By Brian Hartz
  • | 6:00 a.m. August 16, 2019
  • | 0 Free Articles Remaining!
Mark Wemple. David Nixon, an early investor in Informed DNA, is also the CEO.
Mark Wemple. David Nixon, an early investor in Informed DNA, is also the CEO.
  • Strategies
  • Share

Rising demand for clinical genetic testing — brought on by advances in what’s known as precision or personalized medicine, which tailors treatments to suit a person’s unique gene code — has created a niche that St. Petersburg-based InformedDNA is ready to fill.

Founded in 2007 by Tampa clinical geneticist Rebecca Sutphen, the original business model was to be a provider of genetic counseling services to individuals. The firm reinvented its business model in 2013 to focus on working with health insurance companies, which often need outside experts to analyze genetic tests physicians aren’t qualified to examine and interpret for patients.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content